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Modern humans are the most encephalised of all species, with a brain that has more than tripled in 
size over the last 3 million years, much thanks to a dramatically enlarged neocortex. Yet being so big 
doesn’t come cheap and fuelling the brain is energetically expensive. Indeed, despite weighing less 
than 2 % body mass, we allocate a disproportionate 20 % of the body’s resting basal oxygen (O2) 
budget to maintaining its “dark energy”, equating to a cerebral metabolic rate of oxygen (CMRO2) of 
~3 mL/min/100g, more than 10 times that expected from its mass alone. Any interruption in the 
continuous supply of precious O2 can spell disaster for the brain given its almost exclusive reliance 
on aerobic metabolism and baffling lack of energy reserve (Bailey, 2019).   
Since its O2 supply is indeed so delicate, it would seem intuitive for evolution to favour feedback 
mechanisms capable of “sensing” subtle changes in blood O2 concentration and transmitting signals 
to the cerebrovasculature coupling local cerebral O2 delivery (cDO2) to tissue metabolic demand. Yet 
precisely how the brain “titrates” cDO2, the product of cerebral blood flow (CBF) and arterial O2 
content (caO2), fundamental components of the Fick Principle underlying convective cerebral O2 
transport, remains enigmatic. What is clear is that too little or too much of this paradoxically toxic, 
mutagenic gas can ultimately kill you; the brain balances precariously on a bioenergetic tightrope 
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In this issue of Experimental Physiology, Howe et al. (2019) went to considerable lengths to explore 
precisely this, elegantly highlighting the brain’s “balancing act” in response to differential 
manipulations in red blood cell (RBC) mass during acclimatisation to terrestrial high-altitude (HA) 
hypoxia and following acute hypervolemic haemodilution. Specifically, they sought to isolate to what 
extent haemoconcentration contributes to changes in CBF independent of ventilatory adaptation 
throughout the course of acclimatisation, concluding that (the) “CBF response…is generated 
(primarily) by diuresis and erythropoiesis-mediated increases in haemoglobin (Hb) and haematocrit 
(Hct), while the remaining contribution…is likely attributable to ventilatory acclimatization”. The 
authors consistently observed inverse relationships between changes in caO2 (and not PaO2) and CBF 
such that cDO2 remained invariant throughout, that is, well preserved, consistent with the 
conservation of mass principle (Ainslie et al., 2016; Bailey et al., 2017).  
That CBF is primarily governed by compensatory changes in caO2 and not PaO2 (i.e. “bound” in terms 
of saturation and carrying capacity and not “free” O2) to maintain convective O2 delivery extends 
earlier works incorporating haemodilution/carbon monoxide (CO) interventions and in acute/chronic 
anaemia (reviewed in Hoiland et al., 2016). Furthermore, isovolumic haemodilution is associated 
with blunted cerebral hypoxic vasodilatation and CDO2 attributable to attenuated desaturation 
(reviewed in Ainslie et al., 2016; Hoiland et al., 2016). Of note in the current study, albeit in the face 
of hypervolemia, the authors observed an equivalent suppression in cerebral perfusion (upon 
mathematical correction for full restoration of Hct) independent of (unaltered) arterial O2 saturation 
(Howe et al., 2019).   
Collectively, these findings single out the erythrocyte as an important regulator of cerebral hypoxic 
vasodilation with Hb [more specifically, the allosteric shift from relaxed (oxygenated) to tense 
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from neurons, astrocytes, pericytes and smooth muscle cells. Considerable evidence supports an 
increasingly important role for nitric oxide (NO) with the stable metabolites nitrite (NO

2 ) and S-
nitrosohaemoglobin (SNO-Hb) prime candidates given their ability to conserve and transfer 
bioactivity “long-distance” within the cerebral microcirculation (Bailey et al., 2017) (Figure 1).  
However, there are some incongruencies, indeed la “bete noire” lies with the fact that 
pharmacological blockade of NO fails to fully attenuate the CO- or systemic hypoxia-induced 
vasodilatation during exercise (Gonzalez-Alonso et al., 2001). Equally, mathematical approximation 
of the deoxyHb “stimulus” [i.e. deoxyHb mass to blood volume (BV) ratio] estimated as [1-
(SaO2/100) × total Hb mass (Hb concentration × BV)/BV] based on the current data reported by 
Howe et al., (2019), indicates that haemodilution should have invoked less (NO-mediated) 
vasodilatation (24 vs. pre-haemodilution control value of 27 g/L), excluding potential NO-mediated 
contributions caused by blood viscosity-induced alterations in shear-stress (see below). Thus, NO 
(deoxyHb) paints a powerful picture, but it’s clearly not the only artist at play; spare a thought for 
blood viscosity! 
Indeed, notwithstanding contributions from other mediators including β-adrenergic receptor 
activation, prostaglandins, epoxyeicosatrienoic acids, ATP-sensitive potassium channels and 
adenosine, future researchers should give some thought to free radical-mediated activated 
coagulation and altered plasma viscosity (Figure 1). This makes intuitive sense given the inextricable 
relationship between Hb (primary determinant of caO2) and Hct (major component of blood 
viscosity). However, despite an albeit limited body of literature, the weight of evidence favours caO2 
over viscosity, implying that cerebral O2 transport is actively regulated and not simply a passive 
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But let’s get back to that (spared) thought. Emerging evidence suggests that hypoxia and exercise-
induced activated coagulation is indeed subject to redox-regulation subsequent to a free radical-
mediated increase in the bioactivity of coagulation factor VIII and von Willebrand factor 
notwithstanding the oxidative-inactivation of bioactive NO that can also trigger platelet aggregation 
and thrombin formation that collectively increase blood viscosity (Fall et al., 2018). Indeed, it is 
becoming increasingly clear that hypoxia shifts the endothelial phenotype towards one in which 
anticoagulant properties decrease and pro-oxidative-inflammatory-nitrosative stress dominates the 
endovascular milieu (Bailey et al., 2019). Likewise, a reduction in blood viscosity following 
haemodilution could potentially suppress vascular shear-induced endothelial NO-mediated cerebral 
vasodilatation, as rightfully highlighted by the current authors (Howe et al., 2019).  
The new information presented by Howe et al. (2019) makes an important contribution to a complex 
and clinically relevant topic while encouraging the need for further research. Human translational 
physiological approaches that take advantage of low and high viscosity replacement fluids, 
pharmacological NO blockade (neuronal and endothelial), regional (trans-cerebral) sampling of 
bioactive metabolites including blood gas analysis to quantify cerebral O2 extraction (the “forgotten 
sister” and final link in convective cerebral O2 transport) will ultimately help resolve the relative 
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Legend 
Figure 1. The “push, pull and nudge” of cerebral oxygen delivery in hypoxia; a bioenergetic 
tightrope 
Summary of the vascular, rheological, pulmonary and renal pathways underpinning the integrated 
regulation of cerebral blood flow (CBF) during differential manipulations in red blood cell (RBC) mass 
incurred by hypoxia (↑) or haemodilution (↓). Given that haemoglobin (Hb), the primary 
determinant of arterial oxygen content (caO2) and haematocrit (Hct), the primary determinant of 
blood viscosity are intimately related, isolating their independent roles in the regulation of CBF has 
traditionally proven challenging. Both caO2 (vascular “push”) and viscosity (rheological “pull”) are 
inversely related to CBF in the healthy brain consistent with the observations reported by Howe et 
al., (2019) with the former considered the dominant stimulus notwithstanding comparatively minor, 
albeit important contributions from changes in acid-base balance (pulmonary/renal “nudge”). 
Viscosity is considered the primary contributor in the diseased (ischaemic) brain given that cerebral 
vasodilatation is (at or close to) maximal. A reduction in caO2 such as that encountered during 
hypoxia and corresponding allosteric modification of Hb from the oxygenated to deoxygenated state 
allows for NO bioactivity to escape the RBC resulting in compensatory hypoxic vasodilatation (left-
hand side). Equally, making blood “thinner” through haemodilution decreases Hct and plasma 
viscosity increasing cerebral perfusion consistent with the Hagen-Poiseuille equation, albeit 
constrained within the context of a compliant system (right-hand side). All three mechanisms are 
subject to redox-regulation and collectively strive to maintain cerebral O2 delivery (CDO2) and 
optimise O2 transport/cellular partial pressure of O2 (PO2) given the brain’s inherent vulnerability to 
energetic failure. However, it is important to note that haemodilution typically fails to adequately 
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long-term impairment (reviewed in Hoiland et al., 2016). Hatched, colour-coded (traffic light) boxes 
tentatively “rank” those mechanisms considered most important in the current publication (green, 
amber, red). CMRO2, cerebral metabolic rate of oxygen; CBF, cerebral blood flow; caO2/cvO2, 
arterial/venous O2 content; DO2, O2 delivery; oxy/deoxyHb, oxygenated/deoxygenated haemoglobin; 
NO

2 , nitrite; ATP, adenosine triphosphate; SNO-Hb, S-nitrosohaemoglobin NO, nitric oxide; OXINOS, 
oxidative-inflammatory-nitrosative stress; Q, flow; P1-P2, pressure gradient; R, resistance; η, 
viscosity; L, length; r, radius.  
 
 
 
